📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells. (2023)

First Author: Pridgeon CS

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.46582/jsrm.1901002

PubMed Identifier: 37366409

Publication URI: http://europepmc.org/abstract/MED/37366409

Type: Journal Article/Review

Volume: 19

Parent Publication: Journal of stem cells & regenerative medicine

Issue: 1

ISSN: 0973-7154